Predictive Toxicity and Response to Immunotherapy in Patients with Metastatic Non Small Cell Lung Cancer (IMMUNOPREDICT)

被引：0
|
作者：
Nguyen, J. [1 ]
Quere, G. [1 ]
Descourt, R. [1 ]
Geier, M. [1 ]
Babey, H. [1 ]
Saliou, P. [1 ]
Picard, J. [1 ]
Dhamelincourt, E. [1 ]
Fave, T. [1 ]
Laune, Q. [1 ]
Simaki, A. [1 ]
Renaud, E. [1 ]
Cornec, D. [1 ]
机构：
[1] CHRU Brest, Brest, France
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
immunotherapy; prediction; toxicity;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP11.02-08
引用
收藏
页码：S618 / S618
页数：1
相关论文
共 50 条
  • [21] Sarcopenia as a Predictive Factor for Carboplatin Toxicity in Patients with Advanced Non-Small Cell Lung Cancer
    Turcott, Jenny G.
    Miyagui, Sayako M.
    Torres, Salvador Gutierrez
    Cardenas-Fernandez, Daniela
    Caballe-Perez, Enrique
    Rios-Garcia, Eduardo
    Cardona, Andres F.
    Rolfo, Christian
    Arrieta, Oscar
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2024, 76 (10): : 985 - 993
  • [22] Sarcopenia as a Predictive Factor of Carboplatin Toxicity in Patients with Advanced Non-small Cell Lung Cancer
    Turcott, J.
    Miyagui, S. M.
    Caballe-Perez, E.
    Gutierrez Torres, S. Salvador
    Daniela Cardenas-Fernandez, D.
    Eduardo Rios-Garcia, E.
    Cardona, A. F.
    Rolfo, C. Christian
    Arrieta, O.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S607 - S608
  • [23] Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer
    Raimondi, Alessandra
    Sepe, Pierangela
    Zattarin, Emma
    Mennitto, Alessia
    Stellato, Marco
    Claps, Melanie
    Guadalupi, Valentina
    Verzoni, Elena
    de Braud, Filippo
    Procopio, Giuseppe
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [24] Analysis of correlations between driver mutations and biomarkers with response to immunotherapy in patients with metastatic non-small cell lung cancer (NSCLC).
    Yio, Jiang
    Wolf, Brian
    Yang, Amber
    Bayewitz, Ashrei Y.
    Xu, Yiqing
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [25] Comparison of Response and Survival in Patients of Metastatic Non-Small-Cell Lung Cancer Receiving SBRT and Concurrent Immunotherapy-SBRT
    Sridhar, P. S.
    Roopesh, K.
    Muttagi, V.
    Deputy, M.
    Bharathan, A.
    Anuradha, P.
    Hussain, S.
    Thungappa, S. Chirodoni
    Patil, S.
    Jayappa, S. B.
    Kiarie, G. W.
    Kallur, K.
    Mahesh, A.
    Kasumba, L. A.
    Vineet, G.
    Gupta, M.
    Venkatachala, K.
    Bijina, T.
    Ram, A.
    Kumar, B. Ajai
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E146 - E146
  • [26] Immunotherapy in frail non-small-cell lung cancer patients
    Gijtenbeek, Rolof G. P.
    Noordhof, Anneloes L.
    Asmara, Oke D.
    Groen, Harry J. M.
    van Geffen, Wouter H.
    LANCET, 2024, 403 (10440): : 1986 - 1986
  • [27] Neoadjuvant Immunotherapy for Patients with non-small cell Lung Cancer
    Luecke, E.
    Ganzert, C.
    Waesche, A.
    Walles, T.
    Schreiber, J.
    PNEUMOLOGIE, 2020, 74 : S74 - S75
  • [28] Immunotherapy rechallenge in patients with non-small-cell lung cancer
    Espana, S.
    Guasch, I.
    Carcereny, E.
    PULMONOLOGY, 2020, 26 (04): : 252 - 254
  • [29] Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Therapeutic Advances and Biomarkers
    Russano, Marco
    La Cava, Giulia
    Cortellini, Alessio
    Citarella, Fabrizio
    Galletti, Alessandro
    Di Fazio, Giuseppina Rita
    Santo, Valentina
    Brunetti, Leonardo
    Vendittelli, Alessia
    Fioroni, Iacopo
    Pantano, Francesco
    Tonini, Giuseppe
    Vincenzi, Bruno
    CURRENT ONCOLOGY, 2023, 30 (02) : 2366 - 2387
  • [30] Immunotherapy for metastatic non-small cell lung cancer: Is it really a no-brainer?
    Young, Lauren K.
    Halmos, Balazs
    CANCER, 2024, 130 (15) : 2577 - 2581
12345